ArticleBritish journal of cancer2014

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib.

A J C Pommier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.